Anti-dsDNA/ssDNA Antibody (3D8)

Catalog No.

RGK23951

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Applications

DB, ELISA

Target

DNA

Concentration

1.95 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Form

Liquid

Storage buffer

100 mM Pro-Ac, 20 mM Arg, pH 5.0

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

3D8

Note

For research use only.

Construction and evaluation of glucocorticoid dose prediction model based on genetic and clinical characteristics of patients with systemic lupus erythematosus., PMID:40186486

A novel IgD-FcδR blocker, IgD-Fc-Ig fusion protein, effectively alleviates abnormal activation of T cells the disease progression in systemic lupus erythematosus., PMID:40194603

A Retrospective Study of Clinical Characteristics and Serological Profile of Male Systemic Lupus Erythematosus Patients in India., PMID:40200610

Application of machine learning in assessing disease activity in SLE., PMID:40204296

Isolated anti-ribosomal P antibodies are associated with reduced risk of renal and articular involvement in systemic lupus erythematosus patients. An observational study from one center., PMID:40206226

False Positive C-ANCA Caused by Antinuclear Antibody: a Case Report and Literature Review., PMID:40209788

Coexistence of antinucleosome and anti-double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients., PMID:40245259

[The effects of S100A9 gene knockout on lupus-like phenotype in mice]., PMID:40260564

Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis., PMID:40264008

Collapsing Focal Segmental Glomerulosclerosis With Concurrent IgG4 Nephropathy., PMID:40264599

Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteria., PMID:40274305

Proteomics uncovers ICAM2 (CD102) as a novel serum biomarker of proliferative lupus nephritis., PMID:40274316

Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort., PMID:40276498

Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review., PMID:40283389

The Recurrence of Systemic Diseases in Kidney Transplantation., PMID:40283422

Bilateral Periorbital Erythema and Swelling as an Initial Presentation of Systemic Lupus Erythematosus: A Rare Case., PMID:40289991

Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System)., PMID:40294976

Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients., PMID:40302194

Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study., PMID:40310587

Nailfold capillaroscopy changes in systemic lupus erythematosus patients: Correlation with disease activity and anti-uridin1-ribonucleoprotein antibodies., PMID:40316396

Effects of telitacicept in SLE patients with antiphospholipid antibody positivity: a retrospective self-controlled case series., PMID:40317459

Jieduquyuziyin prescription suppresses the activation of the extrafollicular effector B cell by regulating integrin αV signaling in systemic lupus erythematosus., PMID:40318773

From Prescription to Predicament: A Case of Semaglutide-Induced Discoid Lupus Erythematosus in an Adult Male Patient., PMID:40330408

Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides., PMID:40334619

Delayed seropositive lupus nephritis: a clinical dilemma., PMID:40341080

Glucocorticoids discontinuation in systemic lupus erythematosus: a single-centre study., PMID:40342521

Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes., PMID:40343598

Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE., PMID:40350373

Umbilical cord mesenchymal stem cell-derived secretome as a potential treatment for systemic lupus erythematosus: A double-blind randomized controlled trial., PMID:40352183

Differences in dynamics of specific anti-nuclear antibodies and their susceptibility to B cell targeting treatment in Systemic Lupus Erythematosus., PMID:40356198

The hidden pathology: An autopsy diagnosis of unsuspected juvenile systemic lupus erythematosus., PMID:40361200

Validation of eight endotypes of lupus based on whole-blood RNA profiles., PMID:40368437

Effect of rituximab on long-term damage acquisition in patients with systemic lupus erythematosus., PMID:40372703

A serum biomarker panel and miniarray detection system for tracking disease activity and flare risk in lupus nephritis., PMID:40375995

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study., PMID:40377765

Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response., PMID:40395345

Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study., PMID:40408235

The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection., PMID:40424949

The role of IL-39 in autoimmune diseases: From general to immunopathogenesis., PMID:40440970

Double Trouble: A Case Report of Hydralazine-Induced Vasculitis and Lupus., PMID:40443627

Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumab., PMID:40455606

EXPRESS: Diagnostic Discrepancies: A Retrospective Analysis of Two Anti-Nuclear Antibody Platforms., PMID:40459017

Clinically Relevant Cutoffs for Anti-Extractable Nuclear Antigen Line Immunoassays., PMID:40460086

Single-centre comparison of non-familial, familial and monogenic lupus., PMID:40465409

MBD2 promotes B cell differentiation and BCR signaling in systemic lupus erythematosus by regulating the LEF-1-PTEN-PI3K axis., PMID:40467564

SLE complicated with Nocardia farcinica bloodstream infection and disseminated nocardiosis: a case report., PMID:40468247

Frequency of the AC-2 pattern's new variant (AC-30) and detection of different immunological relationships., PMID:40482790

Luminex-based pilot study identifies novel serum autoantibodies associated with disease activity in patients with lupus nephritis., PMID:40500568

Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus., PMID:40516124

Ginsenoside Compound K Mitigates Mitochondrial Fission Through Bile Acid Receptors/YAP Signaling to Counteract Podocyte Injury in Lupus Nephritis., PMID:40528637

Document Download

Anti-dsDNA/ssDNA Antibody (3D8).pdf